======= KANSL1 ======= == Gene Information == * **Official Symbol**: KANSL1 * **Official Name**: KAT8 regulatory NSL complex subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=284058|284058]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z3B3|Q7Z3B3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KANSL1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KANSL1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612452|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a nuclear protein that is a subunit of two protein complexes involved with histone acetylation, the MLL1 complex and the NSL1 complex. The corresponding protein in Drosophila interacts with K(lysine) acetyltransferase 8, which is also a subunit of both the MLL1 and NSL1 complexes. [provided by RefSeq, Jun 2012]. * **UniProt Summary**: N/A No Pfam Domain information is available for this gene. |NSL complex| |histone acetyltransferase activity (H4-K16 specific)| |histone acetyltransferase activity (H4-K8 specific)| |histone acetyltransferase activity (H4-K5 specific)| |histone H4-K8 acetylation| |histone H4-K5 acetylation| |histone H4-K16 acetylation| |histone acetyltransferase complex| |histone acetyltransferase binding| |MLL1 complex| |histone H4 acetylation| |condensed chromosome kinetochore| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.99| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.75| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.72| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|1.75| |[[:results:exp485|GSK626616 14μM R08 exp485]]|1.77| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|1.78| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.8| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.8| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.87| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|1.88| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.91| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|2.01| |[[:results:exp280|Daidzin 10μM R06 exp280]]|2.07| |[[:results:exp134|MS023 2μM R03 exp134]]|2.09| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|2.09| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.12| |[[:results:exp85|UM0129480 7μM R02 exp85]]|2.13| |[[:results:exp285|GW501516 25μM R06 exp285]]|2.36| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.41| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.46| |[[:results:exp67|BVD-523 15μM R02 exp67]]|2.76| ^Gene^Correlation^ |[[:human genes:m:mcrs1|MCRS1]]|0.519| |[[:human genes:k:kansl3|KANSL3]]|0.493| |[[:human genes:k:kansl2|KANSL2]]|0.466| |[[:human genes:p:prim1|PRIM1]]|0.44| Global Fraction of Cell Lines Where Essential: 31/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|1/28| |bone|1/25| |breast|1/33| |central nervous system|2/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|2/21| |liver|0/20| |lung|1/75| |lymphocyte|0/14| |ovary|2/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|1/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1373 * **Expression level (log2 read counts)**: 6.61 {{:chemogenomics:nalm6 dist.png?nolink |}}